ヒストン脱酸化酵素7は,マトリックス金属プロテイン酶10を抑制することによって,血管の完全性を維持する
Shurong Chang1, Bryan D Young, Shijie Li
1Department of Molecular Biology, The University of Texas Southwestern Medical Center at Dallas, TX 75390, USA.
Cell
|July 29, 2006
まとめ
ヒストン脱酸化酵素7 (HDAC7) は,胚の発達中にマトリックス金属タンパク質酶10 (MMP10) を抑制することによって,血管の完全性を維持します. HDAC7の喪失は血管の欠陥を引き起こし,心臓血管の恒常性における重要な役割を強調する.
科学分野:
- 心血管生物学 心血管生物学
- 発達生物学 発達生物学とは
- 分子遺伝学 分子遺伝学
背景:
- 心血管系の発達は,内皮細胞と滑らかな筋肉細胞の相互作用に依存しています.
- 血管の整合性は,機能的な循環網を形成するために不可欠です.
研究 の 目的:
- 心血管疾患の発達におけるヒストン脱酸化酵素7 (HDAC7) の役割を調査する.
- HDAC7が血管の完全性を調節する分子メカニズムを解明する.
主な方法:
- HDAC7遺伝子に障害があるマウスモデルを利用した.
- マトリックス金属プロテイン酶10 (MMP10) の遺伝子発現を分析した.
- HDAC7とミオサイト増強因子-2 (MEF2) の間のタンパク質とタンパク質の相互作用を調査した.
主要な成果:
- HDAC7は,胚形成中に血管内皮に特異的に発現する.
- HDAC7はMMP10の発現を抑制し,細胞外マトリックス分解を防ぐ.
- HDAC7の障害は,内皮細胞の粘着が失敗し,血管の破裂のために胚の致死につながる.
- HDAC7はMEF2と相互作用し,MMP10の転写を抑制する.
結論:
- HDAC7は,胚の発達中に血管の完全性を維持する上で重要な役割を果たします.
- HDAC7-MEF2経路は,MMP10の調節と適切な血管形成の確保に不可欠です.
- この発見は,心血管疾患における血管新生と血管再構成の理解に意味を持ちます.
さらに関連する動画
関連する概念動画
00:49The Blood-brain Barrier
47.3K
Overview
47.3K
01:24Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
01:23Role of Matrix Metalloproteases in Degradation of ECM
2.9K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.9K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:16Vascular Spasm
4.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.9K
01:16Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K